VACCIN: HPV Vaccine Efficacy Trial Replication Data

Replication data for the VACCIN clinical trial aims to establish the superiority of a nonavalent HPV vaccine over placebo in preventing CIN II-III recurrence after treatment. The dataset includes outcomes from a two-year follow-up period. It was authored by van de Laar, Ralf and harvested by DataverseNL.

Use Cases

• Assessing vaccine efficacy based on recurrence outcomes over a two-year follow-up
• Comparing treatment and placebo groups for CIN II-III recurrence rates
• Replicating the statistical analysis of the original VACCIN trial
• Supporting meta-analyses on adjuvant HPV vaccine treatments

Strengths

• Data is specifically for replication of a published clinical trial
• Follow-up period is explicitly defined as two years

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment

Provenance

Source

DataverseNL Harvested Dataverse

Collection Method

Replication data from a clinical trial

Time Range

Two-year follow-up period

Freshness

Last updated 2026-06-22 06:10:16; freshness should be verified